Denali Therapeutics Inc. Common Stock DNLI
$24.82
-1.78%
at last close
Analyst Consensus
- Consensus Rating
- Buy (12 Buy · 1 Hold · 0 Sell)
- Average Price Target
- $35.27
- Implied Upside
- +42.1%
- Price Target Range
- $23.00 – $42.00
- Analysts (12 mo)
- 13
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-07 | UBSMichael Yee |
Maintains | Buy | $25 → $34 |
| 2026-07-23 | Morgan StanleyMatthew Harrison |
Maintains | Overweight | $35 → $36 |
| 2026-07-16 | Deutsche BankDavid Hoang |
Maintains | Buy | $31 → $35 |
| 2026-07-13 | JP MorganJessica Fye |
Reinstates | Overweight | $29 |
| 2026-05-26 | Morgan StanleyMatthew Harrison |
Maintains | Overweight | $40 → $35 |
| 2026-05-14 | Morgan StanleyMatthew Harrison |
Maintains | Overweight | $42 → $40 |
| 2026-05-11 | BTIGThomas Shrader |
Reiterates | Buy | $39 |
| 2026-05-08 | WedbushLaura Chico |
Maintains | Outperform | $25 → $23 |
| 2026-04-22 | Leerink PartnersMarc Goodman |
Maintains | Outperform | $40 → $35 |
| 2026-04-07 | BairdJoel Beatty |
Maintains | Outperform | $32 → $34 |
| 2026-03-26 | Morgan StanleyMatthew Harrison |
Maintains | Overweight | $40 → $42 |
| 2026-03-26 | Goldman SachsSalveen Richter |
Maintains | Buy | $35 → $40 |
| 2026-03-26 | StifelPaul Mattels |
Maintains | Buy | $34 → $41 |
| 2026-03-26 | BairdJoel Beatty |
Maintains | Outperform | $29 → $32 |
| 2026-03-26 | HC Wainwright & Co.Andrew S. Fein |
Maintains | Buy | $32 → $42 |
| 2026-03-25 | BTIGThomas Shrader |
Maintains | Buy | $36 → $38 |
| 2026-03-02 | BTIGThomas Shrader |
Maintains | Buy | $32 → $36 |
| 2026-02-24 | Wolfe ResearchRudy Li |
Initiates coverage on | Peer perform | — |
| 2026-02-06 | BTIGThomas Shrader |
Reiterates | Buy | $32 |
| 2026-01-07 | UBSMichael Yee |
Assumes | Buy | $25 |
| 2025-12-11 | WedbushLaura Chico |
Maintains | Outperform | $31 → $30 |
| 2025-12-05 | WedbushLaura Chico |
Maintains | Outperform | $30 → $31 |
| 2025-12-05 | BTIGThomas Shrader |
Reiterates | Buy | $32 |
| 2025-11-04 | JP MorganJessica Fye |
Maintains | Overweight | $24 → $26 |
| 2025-09-08 | Cantor FitzgeraldJosh Schimmer |
Reiterates | Overweight | — |
| 2025-08-18 | Morgan StanleyMatthew Harrison |
Maintains | Overweight | $33 → $30 |
| 2025-05-19 | B of A SecuritiesTazeen Ahmad |
Maintains | Buy | $28 → $27 |
| 2025-05-08 | BairdJoel Beatty |
Maintains | Outperform | $30 → $29 |
| 2025-05-07 | WedbushLaura Chico |
Maintains | Outperform | $32 → $30 |
| 2025-05-07 | HC Wainwright & Co.Andrew Fein |
Maintains | Buy | $80 → $32 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $24.82
- Market Cap
- $4.04 billion
- 52-Week Range
- $12.58 – $27.30
- Average Volume
- 1.65 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.